“Attracting and Sustaining Big Pharma Acquisition & Investment”

Robert Hariri of Celgene Cellular Therapeutics  joined us for Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Attracting and Sustaining Big Pharma Acquisition & Investment’  Download his presentation now to learn about: The value of innovation Innovation: Longer Life Through Better Medicines The payoff of biomedical innovation What attracts big pharma to our industry? …and much more! Get your copy …

Continuous integrated upstream and downstream processes: a viable option for the future of big pharma?

Is a continuous upstream and downstream process a viable option for the future? Integrated upstream and downstream technology seems to be the ‘holy grail’ of what can be expected for the future of biosimilar drug extraction. Industry pharma leaders such as Genzyme, GE Healthcare, and Novo Nordisk and CMO companies such as Gallus and Rentschler are all working on pushing the …

Filling the Innovation Gap with Big Data

Data and information form the cornerstone of innovation, and it will take a change in mindset for the pharmaceutical industry to fill the innovation gap and change the way drug research is conducted. Drug approval has been flat for the last two decades, while the cost of drug development is constantly rising. Solid real world evidence of the drug performance …

Clinical Trials: Cooperation and Big Data Sharing is the Way Forward

Big Pharma companies are hiring Big Data analytics firms to protect privacy of shared data Important initiatives are emerging for big pharma companies to render their trials results accessible to other companies and to researchers. The spread of this tendency would make drug development more efficient and save the industry billions. Indeed, if researchers could always see which mistakes rivals …

big data big pharma

Announcing The Marriage of Big Pharma and Big Data

Novartis teams up with Google to develop “smart” lens This week a partnership between Goggle and Novartis has been announced, for the development of a “smart” contact lens to help diabetics track their blood sugar levels. This is the first big partnership made public between big pharma and big data to work together to revolutionise chronic disease monitoring and treatment. …

big pharma firepower in global pharma m&a

Big pharma’s position in global pharma M&A – exploring EY’s ‘Firepower’ report

Last year saw pharmaceutical mergers and acquisitions increase by $45 billion (click here to read a recent Total Biopharma post about it). However, the activities of big pharma in these M&As were somewhat marginalised, with the majority of acquisitions completed by speciality pharma and big biotech. As reported in Financier.com, Ernst & Young’s report, ‘Firepower and Growth Gap’, states that …

Download: The role of big pharma interview with Rino Rappuoli

What is the role of big pharma? This is what we asked Dr Rino Rappuoli, Global Head of Vaccines Research, Novartis Vaccines and Diagnostics in our series Vaccine Viewpoints. “How do you feel the role of big pharma is going to change in the vaccine industry in the coming year, and what are Novartis doing to ensure continuing success? Overall, I think companies …

Can Orphan Drugs Soften the Blow of the Patent Cliff?

With an estimated $67 billion worth of biosimilar patents due to expire before 2020, as reported by GaBI in a guest blog for TotalBiopharma, increasing research and development costs, and slowing rates of approval for mass market drugs currently under development, how are some of the world’s leading pharmaceutical companies planning to avoid falling off the patent cliff? Well, a …

How Long Before We Have the Universal Availability of Insulin

According to the International Diabetes Federation, there are over 371 million people around the world who suffer from diabetes. And yesterday, 14th November, marked 2013’s World Diabetes Day. The day, aimed at raising awareness and support for those suffering from the infliction, saw events take place across the globe and as well as organisations lighting up national monuments blue in …